You have free access to this content

Hepatology

Cover image for Vol. 56 Issue 6

December 2012

Volume 56, Issue 6

Pages 2013–1535

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
    2. You have free access to this content
  2. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B (pages 2018–2026)

      Karen F. Murray, Leszek Szenborn, Jacek Wysocki, Stephen Rossi, Amoreena C. Corsa, Phillip Dinh, John McHutchison, Phillip S. Pang, Luminita M. Luminos, Malgorzata Pawlowska and Jacek Mizerski

      Version of Record online: 27 AUG 2012 | DOI: 10.1002/hep.25818

    2. You have free access to this content
      Targeted delivery of interferon-α to hepatitis B virus-infected cells using T-cell receptor-like antibodies (pages 2027–2038)

      Changhua Ji, Konduru S.R. Sastry, Georg Tiefenthaler, Jennifer Cano, Tenny Tang, Zi Zong Ho, Denise Teoh, Sandhya Bohini, Antony Chen, Surya Sankuratri, Paul A. Macary, Patrick Kennedy, Han Ma, Stefan Ries, Klaus Klumpp, Erhard Kopetzki and Antonio Bertoletti

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25875

    3. You have free access to this content
      High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials (pages 2039–2050)

      Patrick Marcellin, Hugo Cheinquer, Manuela Curescu, Geoffrey M. Dusheiko, Peter Ferenci, Andrzej Horban, Donald Jensen, Gabriella Lengyel, Alessandra Mangia, Denis Ouzan, Massimo Puoti, Maribel Rodriguez-Torres, Mitchell L. Shiffman, Manuela Schmitz, Fernando Tatsch and Mario Rizzetto

      Version of Record online: 8 AUG 2012 | DOI: 10.1002/hep.25892

    4. You have free access to this content
      Hepatitis B virus X protein modulates oncogene yes-associated protein by CREB to promote growth of hepatoma cells (pages 2051–2059)

      Tao Zhang, Junping Zhang, Xiaona You, Qian Liu, Yumei Du, Yuen Gao, Changliang Shan, Guangyao Kong, Youliang Wang, Xiao Yang, Lihong Ye and Xiaodong Zhang

      Version of Record online: 19 JUL 2012 | DOI: 10.1002/hep.25899

    5. You have free access to this content
      IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection (pages 2060–2070)

      Heiyoung Park, Elisavet Serti, Onyinyechi Eke, Brian Muchmore, Ludmila Prokunina-Olsson, Stefania Capone, Antonella Folgori and Barbara Rehermann

      Version of Record online: 19 NOV 2012 | DOI: 10.1002/hep.25897

    6. You have free access to this content
      Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection (pages 2071–2081)

      Victoria M. Velazquez, Huiming Hon, Chris Ibegbu, Stuart J. Knechtle, Allan D. Kirk and Arash Grakoui

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25904

  3. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication (pages 2082–2093)

      Philippe Metz, Eva Dazert, Alessia Ruggieri, Johanna Mazur, Lars Kaderali, Artur Kaul, Ulf Zeuge, Marc P. Windisch, Martin Trippler, Volker Lohmann, Marco Binder, Michael Frese and Ralf Bartenschlager

      Version of Record online: 14 OCT 2012 | DOI: 10.1002/hep.25908

  4. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Hepatitis c virus-specific t-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis (pages 2094–2105)

      Shaoyong Li, Lianne E.M. Vriend, Imad A. Nasser, Yury Popov, Nezam H. Afdhal, Margaret J. Koziel, Detlef Schuppan, Mark A. Exley and Nadia Alatrakchi

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25951

    2. You have free access to this content
      Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: Results from the REALIZE trial (pages 2106–2115)

      Sandra De Meyer, Inge Dierynck, Anne Ghys, Maria Beumont, Bjorn Daems, Ben Van Baelen, James C. Sullivan, Douglas J. Bartels, Tara L. Kieffer, Stefan Zeuzem and Gaston Picchio

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25962

    3. You have free access to this content
      Hepatitis B virus X protein stimulates gene expression selectively from extrachromosomal DNA templates (pages 2116–2124)

      Pieter C. van Breugel, Eva I. Robert, Henrik Mueller, Adrien Decorsière, Fabien Zoulim, Olivier Hantz and Michel Strubin

      Version of Record online: 24 SEP 2012 | DOI: 10.1002/hep.25928

    4. You have free access to this content
      Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot study (pages 2125–2133)

      Giovanna Ferraioli, Carmine Tinelli, Barbara Dal Bello, Mabel Zicchetti, Gaetano Filice, Carlo Filice and on behalf of the Liver Fibrosis Study Group

      Version of Record online: 31 AUG 2012 | DOI: 10.1002/hep.25936

    5. You have free access to this content
      Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis (pages 2134–2141)

      Norio Akuta, Fumitaka Suzuki, Yuya Seko, Yusuke Kawamura, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Tasuku Hara, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25949

  5. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease (pages 2142–2153)

      Valerio Nobili, Guido Carpino, Anna Alisi, Antonio Franchitto, Gianfranco Alpini, Rita De Vito, Paolo Onori, Domenico Alvaro and Eugenio Gaudio

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25742

    2. You have free access to this content
      Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice (pages 2154–2162)

      Jihong Lian, Enhui Wei, Shu Pei Wang, Ariel D. Quiroga, Lena Li, Alba Di Pardo, Jelske van der Veen, Simonetta Sipione, Grant A. Mitchell and Richard Lehner

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25881

    3. You have free access to this content
      JD induced pluripotent stem cell–derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia (pages 2163–2171)

      Max A. Cayo, Jun Cai, Ann DeLaForest, Fallon K. Noto, Masato Nagaoka, Brian S. Clark, Ross F. Collery, Karim Si-Tayeb and Stephen A. Duncan

      Version of Record online: 17 SEP 2012 | DOI: 10.1002/hep.25871

    4. You have free access to this content
      Pioglitazone and vitamin E for nonalcoholic steatohepatitis: A cost utility analysis (pages 2172–2179)

      Suzanne E. Mahady, Germaine Wong, Jonathan C. Craig and Jacob George

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25887

    5. You have free access to this content
      Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus (pages 2180–2187)

      Ilaria Barchetta, Simone Carotti, Giancarlo Labbadia, Umberto Vespasiani Gentilucci, Andrea Onetti Muda, Francesco Angelico, Gianfranco Silecchia, Frida Leonetti, Antonio Fraioli, Antonio Picardi, Sergio Morini and Maria Gisella Cavallo

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25930

    6. You have free access to this content
      Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia (pages 2188–2198)

      Ariel D. Quiroga, Lena Li, Martin Trötzmüller, Randy Nelson, Spencer D. Proctor, Harald Köfeler and Richard Lehner

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25961

    7. You have free access to this content
      Elovl6 promotes nonalcoholic steatohepatitis (pages 2199–2208)

      Takashi Matsuzaka, Ayaka Atsumi, Rie Matsumori, Tang Nie, Haruna Shinozaki, Noriko Suzuki-Kemuriyama, Motoko Kuba, Yoshimi Nakagawa, Kiyoaki Ishii, Masako Shimada, Kazuto Kobayashi, Shigeru Yatoh, Akimitsu Takahashi, Kazuhiro Takekoshi, Hirohito Sone, Naoya Yahagi, Hiroaki Suzuki, Soichiro Murata, Makoto Nakamuta, Nobuhiro Yamada and Hitoshi Shimano

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25932

    8. You have free access to this content
    9. You have free access to this content
      Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: A case-control study (pages 2221–2230)

      Srinevas K. Reddy, J. Wallis Marsh, Patrick R. Varley, Brady K. Mock, Kapil B. Chopra, David A. Geller and Allan Tsung

      Version of Record online: 14 OCT 2012 | DOI: 10.1002/hep.25935

  6. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy (pages 2231–2241)

      Sheng-Xian Yuan, Fu Yang, Yuan Yang, Qi-Fei Tao, Jin Zhang, Gang Huang, Yun Yang, Ruo-Yu Wang, Sen Yang, Xi-Song Huo, Ling Zhang, Fang Wang, Shu-Han Sun and Wei-Ping Zhou

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25895

    2. You have free access to this content
      Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma (pages 2242–2254)

      Shao-Lai Zhou, Zhi Dai, Zheng-Jun Zhou, Xiao-Ying Wang, Guo-Huan Yang, Zheng Wang, Xiao-Wu Huang, Jia Fan and Jian Zhou

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25907

    3. You have free access to this content
      Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development (pages 2255–2267)

      Kun Wu, Jin Ding, Cheng Chen, Wen Sun, Bei-Fang Ning, Wen Wen, Lei Huang, Tao Han, Wen Yang, Chao Wang, Zhong Li, Meng-Chao Wu, Gen-Sheng Feng, Wei-Fen Xie and Hong-Yang Wang

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.26007

    4. You have free access to this content
      A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver (pages 2268–2276)

      Wangta Liu, Jim-Ray Chen, Chih-Hao Hsu, Yen-Hsing Li, Yi-Meng Chen, Chien-Yuan Lin, Shin-Jie Huang, Zen-Kuei Chang, Yen-Chun Chen, Chi-Hsueh Lin, Hong-Yi Gong, Ching-Chun Lin, Koichi Kawakami and Jen-Leih Wu

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25914

    5. You have free access to this content
      SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma (pages 2277–2287)

      Chun-Ming Tsao, Ming-De Yan, Yu-Lueng Shih, Pei-Ning Yu, Chih-Chi Kuo, Wen-Chi Lin, Hsin-Jung Li and Ya-Wen Lin

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25933

  7. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Liver X receptor β and peroxisome proliferator-activated receptor δ regulate cholesterol transport in murine cholangiocytes (pages 2288–2296)

      Xuefeng Xia, Dongju Jung, Paul Webb, Aijun Zhang, Bin Zhang, Lifei Li, Stephen D. Ayers, Chiara Gabbi, Yoshiyuki Ueno, Jan-Åke Gustafsson, Gianfranco Alpini, David D. Moore and Gene D. LeSage

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25919

  8. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis (pages 2297–2304)

      Bernhard Jäger, Andreas Drolz, Barbara Michl, Peter Schellongowski, Andja Bojic, Miriam Nikfardjam, Christian Zauner, Gottfried Heinz, Michael Trauner and Valentin Fuhrmann

      Version of Record online: 24 SEP 2012 | DOI: 10.1002/hep.25896

    2. You have full text access to this OnlineOpen article
      Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis (pages 2305–2315)

      Yaseen M. Arabi, Saqib I. Dara, Ziad Memish, Abdulmajeed Al Abdulkareem, Hani M. Tamim, Nehad Al-Shirawi, Joseph E. Parrillo, Peter Dodek, Stephen Lapinsky, Daniel Feinstein, Gordon Wood, Sandra Dial, Sergio Zanotti, Anand Kumar and for the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25931

    3. You have free access to this content
      Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent (pages 2316–2327)

      Tomonori Aoyama, Yong-Han Paik, Sumio Watanabe, Benoît Laleu, Francesca Gaggini, Laetitia Fioraso-Cartier, Sophie Molango, Freddy Heitz, Cédric Merlot, Cédric Szyndralewiez, Patrick Page and David A. Brenner

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25938

    4. You have free access to this content
      Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end-stage liver disease (NACSELD) experience (pages 2328–2335)

      Jasmohan S. Bajaj, Jacqueline G. O'Leary, K. Rajender Reddy, Florence Wong, Jody C. Olson, Ram M. Subramanian, Geri Brown, Nicole A. Noble, Leroy R. Thacker, Patrick S. Kamath, and on behalf of NACSELD

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25947

  9. Liver Injury/Regeneration

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice (pages 2336–2343)

      Lisheng Zhang, Yan-Dong Wang, Wei-Dong Chen, Xichun Wang, Guiyu Lou, Nian Liu, Min Lin, Barry M. Forman and Wendong Huang

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25905

    2. You have free access to this content
      Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice (pages 2344–2352)

      Prachi Borude, Genea Edwards, Chad Walesky, Feng Li, Xiaochao Ma, Bo Kong, Grace L. Guo and Udayan Apte

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25918

    3. You have free access to this content
      TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis (pages 2353–2362)

      Muhammad Imran Arshad, Claire Piquet-Pellorce, Annie L'Helgoualc'h, Michel Rauch, Solène Patrat-Delon, Frédéric Ezan, Catherine Lucas-Clerc, Sabrina Nabti, Agnès Lehuen, Francisco Javier Cubero, Jean-Philippe Girard, Christian Trautwein and Michel Samson

      Version of Record online: 24 SEP 2012 | DOI: 10.1002/hep.25893

  10. Liver Biology/Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib (pages 2363–2374)

      Carlo Spirli, Carola M. Morell, Luigi Locatelli, Stefano Okolicsanyi, Cecilia Ferrero, Amy K. Kim, Luca Fabris, Romina Fiorotto and Mario Strazzabosco

      Version of Record online: 27 AUG 2012 | DOI: 10.1002/hep.25872

    2. You have free access to this content
    3. You have free access to this content
      Short-term feedback regulation of bile salt uptake by bile salts in rodent liver (pages 2387–2397)

      Stefanie Mühlfeld, Olga Domanova, Thomas Berlage, Claudia Stross, Angelika Helmer, Verena Keitel, Dieter Häussinger and Ralf Kubitz

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25955

  11. Special Reports

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agents (pages 2398–2403)

      Heiner Wedemeyer, Donald M. Jensen, Eliot Godofsky, Nina Mani, Jean-Michel Pawlotsky, Veronica Miller and on behalf of the Definitions/Nomenclature Working Group* of the HCV DrAG (HCV Drug Development Advisory Group), under the auspices of the Forum for Collaborative HIV Research

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25888

  12. Reviews

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver (pages 2404–2411)

      Claudia Cicione, Chiara Degirolamo and Antonio Moschetta

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25929

  13. Hepatology Elsewhere

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
  14. Clinical Perspectives in Hepatology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Hepatitis E masquerading as drug-induced liver injury (pages 2420–2423)

      Emerson Y. Chen, Karl Baum, William Collins, Arthur Löve, Michael Merz, Sigurdur Olafsson, Einar S. Björnsson and William M. Lee

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.26158

  15. Correspondence

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
      Genetic study of FGF19 receptor variants in gallstone disease (page 2424)

      Marcin Krawczyk, Monica Acalovschi and Frank Lammert

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25863

    2. You have free access to this content
    3. You have free access to this content
      Reply: (page 2425)

      Abhisek Mitra, Jeffry Cutrera, Lopa Mishra and Shulin Li

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25862

    4. You have free access to this content
      Crosstalk between the hepatologist and the cardiologist: A future place for the lithocholic acid as a coronary atheroma risk factor? (page 2426)

      Henri Duboc, Hélène Aelion, Dominique Rainteau, Sylvie Rajca, Harry Sokol, Lydie Humbert, Dominique Farabos, Benoit Coffin, Simon Weber, Raphaël Porcher, Olivier Varenne and Denis Duboc

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25839

    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
      Reply: (pages 2428–2429)

      Christopher H. Remien, Frederick R. Adler, Terry D. Box, Lindsey Waddoups and Norman L. Sussman

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.25940

  16. Obituary

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content
  17. Abstracts

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Autoimmune, Cholestatic and Biliary Disease
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Special Reports
    13. Reviews
    14. Hepatology Elsewhere
    15. Clinical Perspectives in Hepatology
    16. Correspondence
    17. Obituary
    18. Abstracts
    1. You have free access to this content

SEARCH

SEARCH BY CITATION